Sesame oil (CAS 8008-74-0)

The TGF-beta activated kinase 1 (MAP3K7) binding protein family, comprising proteins like TAB1, TAB2, and TAB3, plays a crucial role in cellular signaling pathways. These proteins act as adaptors and regulators for MAP3K7, also known as TAK1, which is a key kinase in response to environmental stress and cytokines. Upon activation, these binding proteins facilitate the formation of a complex with MAP3K7, leading to its activation and subsequent triggering of downstream signaling cascades. These cascades primarily involve the activation of NF-kappaB and AP-1 transcription factors, which regulate gene expression related to inflammation, immunity, and cell survival. Dysregulation in this signaling pathway can lead to various pathological conditions, including inflammatory diseases and cancer. The TGF-beta activated kinase 1 (MAP3K7) binding protein (TAB) inhibitors represent a specific class of chemical compounds designed to modulate the activity of the MAP3K7 signaling pathway by targeting its binding proteins, namely TAB1, TAB2, and TAB3. These inhibitors are primarily focused on disrupting the interaction between MAP3K7 (also known as TAK1) and its associated binding proteins, which are crucial for the proper functioning of the TAK1 signaling complex. This complex is integral to various cellular processes, including the regulation of apoptosis, inflammation, and other critical cellular functions.